E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/2/2021 in the Prospect News Structured Products Daily.

New Issue: Barclays sells $1.33 million autocallable contingent coupon notes on two ETFs

By Kiku Steinfeld

Chicago, Feb. 2 – Barclays Bank plc priced $1.33 million of autocallable contingent coupon notes due Jan. 31, 2023, linked to the lesser performing of the SPDR S&P Biotechnology ETF and the Technology Select Sector SPDR fund, according to a 424B2 filing with the Securities and Exchange Commission.

The notes pay a contingent quarterly coupon at an annualized rate of 12% if each asset closes at or above its coupon barrier level, 75% of its initial level, on the valuation date for that period.

The notes will be called at par plus the coupon due if each ETF closes above its initial level on any quarterly valuation date other than the final one.

If each asset finishes at or above its final barrier level, 75% of its initial level, the payout at maturity will be par plus the coupon. Otherwise, investors will be fully exposed to the decline of the least-performing asset.

Barclays is the agent.

Issuer:Barclays Bank plc
Issue:Autocallable contingent coupon notes
Underlying ETFs:SPDR S&P Biotechnology ETF and Technology Select Sector SPDR fund
Amount:$1,331,000
Maturity:Jan. 31, 2023
Contingent coupon:12% per year, payable quarterly if each asset closes at or above coupon barrier on the valuation date for that period
Price:Par
Payout at maturity:If each asset finishes at or above final barrier, par plus coupon; otherwise, full exposure to losses of least-performing asset
Call:At par plus coupon if each ETF closes above initial level on any quarterly valuation date other than final one
Initial level:$152.30 for Biotech, $131.50 for Technology Select
Coupon barriers:$114.23 for Biotech, $98.63 for Technology Select; 75% of initial levels
Final barriers:$114.23 for Biotech, $98.63 for Technology Select; 75% of initial levels
Pricing date:Jan. 27
Settlement date:Jan. 29
Agent:Barclays
Fees:1.75%
Cusip:06747QZD2

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.